Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorTuran, Gülhan
dc.contributor.authorÖzdemir, Ahmet
dc.contributor.authorKaplancıklı, Zafer Asım
dc.contributor.authorAltıntop, Mehlika Dilek
dc.contributor.authorTemel, Halide Edip
dc.contributor.authorÇiftçi, Gülsen Akalın
dc.date.accessioned2019-10-19T14:44:50Z
dc.date.available2019-10-19T14:44:50Z
dc.date.issued2013
dc.identifier.issn1475-6366
dc.identifier.urihttps://dx.doi.org/10.3109/14756366.2011.653355
dc.identifier.urihttps://hdl.handle.net/11421/13623
dc.descriptionWOS: 000316419400011en_US
dc.descriptionPubMed ID: 22299580en_US
dc.description.abstractIn the present study, some thiazole derivatives were synthesized via the ring closure reaction of 1-[2-(2-oxobenzo[d] thiazol-3(2H)-yl)acetyl]thiosemicarbazide with various phenacyl bromides. The chemical structures of the compounds were elucidated by H-1 NMR, C-13 NMR and mass spectral data and elemental analyses. Each derivative was evaluated for its ability to inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) using a modification of Ellman's spectrophotometric method. The compounds were also investigated for their cytotoxic properties using MTT assay. The most potent AChE inhibitor was found as compound 4e (IC50 = 25.5 +/- 2.12 mu g/mL) followed by compounds 4i (IC50 = 38.50 +/- 2.12 mu g/mL), 4c (IC50 = 58.42 +/- 3.14 mu g/mL) and 4g (IC50 = 68 +/- 2.12 mu g/mL) when compared with eserine (IC50 = 0.025 +/- 0.01 mu g/mL). Effective compounds on AChE exhibited weak inhibition on BuChE (IC50 > 80 mu g/mL). MTT assay indicated that the cytotoxic dose (IC50 = 71.67 +/- 7.63 mu g/mL) of compound 4e was higher than its effective dose.en_US
dc.language.isoengen_US
dc.publisherInforma Healthcareen_US
dc.relation.isversionof10.3109/14756366.2011.653355en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectThiazoleen_US
dc.subjectHydrazideen_US
dc.subjectAnticholinesterase Activityen_US
dc.subjectCytotoxicityen_US
dc.titleSynthesis and biological evaluation of some thiazole derivatives as new cholinesterase inhibitorsen_US
dc.typearticleen_US
dc.relation.journalJournal of Enzyme Inhibition and Medicinal Chemistryen_US
dc.contributor.departmentAnadolu Üniversitesi, Eczacılık Fakültesi, Farmasötik Kimya Anabilim Dalıen_US
dc.identifier.volume28en_US
dc.identifier.issue3en_US
dc.identifier.startpage509en_US
dc.identifier.endpage514en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.contributor.institutionauthorTuran, Gülhan
dc.contributor.institutionauthorÖzdemir, Ahmet
dc.contributor.institutionauthorKaplancıklı, Zafer Asım
dc.contributor.institutionauthorAltıntop, Mehlika Dilek
dc.contributor.institutionauthorTemel, Halide Edip
dc.contributor.institutionauthorÇiftçi, Gülsen Akalın


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster